CASI Pharmaceuticals
CASI
#8877
Rank
S$0.11 B
Marketcap
$7.49
Share price
0.45%
Change (1 day)
23.41%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2024 (TTM): -S$36.27 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are S$23.1 Million. In 2023 the company made an earning of -S$35.45 Million, an increase over its 2022 earnings that were of -S$50.31 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$36.27 Million2.33%
2023 -S$35.45 Million-29.55%
2022 -S$50.31 Million4.43%
2021 -S$48.18 Million-24.56%
2020 -S$63.86 Million4.74%
2019 -S$60.97 Million65.13%
2018 -S$36.93 Million155.07%
2017 -S$14.48 Million13.93%
2016 -S$12.71 Million31.18%
2015 -S$9.69 Million-72.5%
2014 -S$35.22 Million356.62%
2013 -S$7.72 Million-60.55%
2012 -S$19.55 Million218.41%
2011 -S$6.14 Million0.74%
2010 -S$6.1 Million-32.54%
2009 -S$9.04 Million-66.98%
2008 -S$27.36 Million-14.22%
2007 -S$31.9 Million7.04%
2006 -S$29.8 Million27.95%
2005 -S$23.29 Million4.51%
2004 -S$22.29 Million-15.84%
2003 -S$26.48 Million-55.29%
2002 -S$59.23 Million-34.05%
2001 -S$89.8 Million31.73%
2000 -S$68.17 Million31.56%
1999 -S$51.82 Million145.56%
1998 -S$21.11 Million76.4%
1997 -S$11.97 Million36.92%
1996 -S$8.74 Million